ArticleTranslational lung cancer research2019

KEYNOTE-042: is lowering the PD-L1 threshold for first-line pembrolizumab monotherapy a good idea?

Jose M PachecoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.